Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD.
about
Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response.Blood transfusion, serum ferritin, and iron in hemodialysis patients in AfricaTarget Hemoglobin May Be Achieved with Intravenous Iron Alone in Anemic Patients with Cardiorenal Syndrome: An Observational Study.The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationaleFerritin Level Is Positively Associated with Chronic Kidney Disease in Korean Men, Based on the 2010-2012 Korean National Health and Nutrition Examination Survey.Renal anaemia treatment in haemodialysis patients in the Central and Eastern European countries in everyday clinical practice follow-up.Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron.The Labile Side of Iron Supplementation in CKDAnemia in Chronic Obstructive Pulmonary Disease and the Potential Role of Iron Deficiency.The IRONy of Iron-overload and Iron-deficiency in Chronic Obstructive Pulmonary Disease.Multi-factors including Inflammatory/Immune, Hormones, Tumor-related Proteins and Nutrition associated with Chronic Prostatitis NIH IIIa+b and IV based on FAMHES project.The administration of deferasirox in an iron-overloaded dialysis patient.Iron in kidney and heart failure: from theory to practice.Cumulative iron dose and resistance to erythropoietin.The Free Radical Diseases of Prematurity: From Cellular Mechanisms to BedsideSwitching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
P2860
Q30418035-DCE7BBCD-1D18-4ED1-B5A9-2576939EEB01Q35012284-8D09F577-B07A-44F7-849D-DD8D4CBCB194Q36325756-628E330D-E20D-4D11-BD3E-2741F20F4294Q36333126-18BC1AF2-510B-46BB-9307-A53BB35AA2A9Q37455533-451E39C7-0848-423D-9274-E47332E4A5C5Q37526367-253C63DF-3795-4C7D-9713-A5B39E7EACB9Q37623876-73C25E5B-E755-497D-B402-C70DD6C2A5B6Q38496987-2068BB63-B1F8-45C7-AF4D-BD42CC681D65Q38595235-4207ACAD-60C0-42EC-95DA-F88B97A00B3EQ39243181-EFB1011A-7F9C-4454-A2A2-95EC92DF6B3BQ40083765-15E14A7B-17F4-41C2-AAE4-1D4BC0D69D4EQ44244864-9A12F0AA-DB65-4A39-BCE8-7F7DAB370448Q48306942-BAB23B02-BCC0-47E7-A078-B137282014F4Q53150909-DFF76193-5819-4200-B81A-BD5CAFB417EEQ58188912-3AC7FA62-6596-47CF-BF1A-9696C78F07BAQ58711479-B92B29BF-9F44-4F86-A0F4-CAA1DAE70A63
P2860
Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Iron overdose: a contributor t ...... s of anemia correction in CKD.
@ast
Iron overdose: a contributor t ...... s of anemia correction in CKD.
@en
type
label
Iron overdose: a contributor t ...... s of anemia correction in CKD.
@ast
Iron overdose: a contributor t ...... s of anemia correction in CKD.
@en
prefLabel
Iron overdose: a contributor t ...... s of anemia correction in CKD.
@ast
Iron overdose: a contributor t ...... s of anemia correction in CKD.
@en
P2093
P2860
P1476
Iron overdose: a contributor t ...... s of anemia correction in CKD.
@en
P2093
Nosratola D Vaziri
Peter Van Buren
Ruben L Velez
Xin J Zhou
P2860
P304
P356
10.1007/S11255-011-0028-5
P577
2011-07-10T00:00:00Z